title: Rivaroxaban for treatment of HIT: a riveting first experience.
authors.affiliation: Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: linkinla@mcmaster.ca.
authors.forename: Lori-Ann
authors.initials: LA
authors.lastname: Linkins
authors.affiliation: Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: twarken@mcmaster.ca.
authors.forename: Theodore E
authors.initials: TE
authors.lastname: Warkentin
mesh_terms: D065427:Factor Xa Inhibitors / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006494:Heparin Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000627:therapeutic use*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000188:drug therapy*
chemical_list: D065427:Factor Xa Inhibitors; D006494:Heparin Antagonists; D009025:Morpholines; D013876:Thiophenes; D006493:Heparin; D000069552:Rivaroxaban